Doyle Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Doyle Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-480	Closed	-$52K	–	433
2019 Q2	$52K	Buy	+480	New	+$51.1K	0.01%	357
2019 Q1	–	Sell	-105	Closed	-$10K	–	417
2018 Q4	$10K	Buy	+105	New	+$11.1K	﹤0.01%	620

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Doyle Wealth Management's IBB Position: Q3 2019 in Review

Doyle Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 480 shares — an estimated $52K sold.

Doyle Wealth Management first reported a position in IBB in Q4 2018 and held it in 2 quarters. The position peaked at $52K in Q2 2019. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Doyle Wealth Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Doyle Wealth Management sold 480 iShares Biotechnology ETF shares in Q3 2019, an estimated $52K.
Doyle Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 2 quarters.
Doyle Wealth Management's iShares Biotechnology ETF position peaked at $52K in Q2 2019.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Doyle Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.